S'identifier

Danlin Yang

Department of Biotherapeutics Discovery,
Immune Modulation and Biotherapeutics Discovery,
Department of Biotherapeutics Discovery, Immune Modulation and Biotherapeutics Discovery

Boehringer Ingelheim Pharmaceuticals, Inc.

BIOGRAPHY

Danlin Yang has not added Biography.

If you are Danlin Yang and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Efficient Qualitative and Quantitative Determination of Antigen-induced Immune Responses.

The Journal of biological chemistry Jul, 2016 | Pubmed ID: 27288409

Comparison of biosensor platforms in the evaluation of high affinity antibody-antigen binding kinetics.

Analytical biochemistry Sep, 2016 | Pubmed ID: 27365220

Dataset of the binding kinetic rate constants of anti-PCSK9 antibodies obtained using the Biacore T100, ProteOn XPR36, Octet RED384, and IBIS MX96 biosensor platforms.

Data in brief Sep, 2016 | Pubmed ID: 27547794

INSTITUTIONS

Boehringer Ingelheim Pharmaceuticals, Inc.

JOVE ARTICLES

Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms

Danlin Yang¹,

Ajit Singh²,

Helen Wu¹,

Rachel Kroe-Barrett¹

¹Department of Biotherapeutics Discovery, Immune Modulation and Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals, Inc.,

²The Fu Foundation School of Engineering and Applied Science, Columbia University

Biochemistry

Confidentialité

Conditions d'utilisation

Politiques

Contactez-nous

RECOMMANDER À LA BIBLIOTHÈQUE

NEWSLETTERS JoVE

Recherche

JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives

Enseignement

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Faculty Site

Auteurs

Vue d'ensemble
Processus de publication
Comité éditorial
Domaines et politique de publication
Révision par les pairs
FAQ
Soumettre

Bibliothécaires

Vue d'ensemble
Témoignages
Abonnements
Accès
Ressources
Conseil consultatif des bibliothèques
FAQ

À PROPOS DE JoVE

Vue d'ensemble
Direction
Blog
JoVE Help Center

Danlin Yang

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Department of Biotherapeutics Discovery,Immune Modulation and Biotherapeutics Discovery,Department of Biotherapeutics Discovery, Immune Modulation and Biotherapeutics Discovery

Boehringer Ingelheim Pharmaceuticals, Inc.

Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms

Department of Biotherapeutics Discovery,
Immune Modulation and Biotherapeutics Discovery,
Department of Biotherapeutics Discovery, Immune Modulation and Biotherapeutics Discovery